|
311 |
Home advantage in the Winter Paralympic Games 1976–2014
Enthalten in Sport sciences for health Bd. 13, 6.6.2017, Nr. 2, date:8.2017: 355-363
|
|
|
|
312 |
Hospitalization Rates for Acute Myocardial Infarction Among Asian-American Subgroups: Have We Been Underestimating the Problem?
Enthalten in Journal of immigrant and minority health Bd. 20, 18.10.2016, Nr. 1, date:2.2018: 20-25
|
|
|
|
313 |
„How is health created?“
Enthalten in Zeitschrift für Gerontologie und Geriatrie Bd. 49, 15.11.2016, Nr. 8, date:12.2016: 762-764
|
|
|
|
314 |
How medical technologies shape the experience of illness
Enthalten in Life sciences, society and policy Bd. 14, 3.2.2018, Nr. 1, date:12.2018: 1-11
|
|
|
|
315 |
How to Think about Health Promotion Ethics
Enthalten in Public health reviews Bd. 34, 18.4.2017, Nr. 1, date:6.2012: 1-24
|
|
|
|
316 |
HTA in EU: Commission seeks to boost cooperation
Enthalten in PharmacoEconomics & outcomes news Bd. 796, 10.2.2018, Nr. 1, date:2.2018: 33
|
|
|
|
317 |
ICER issues final report on VMAT2 inhibitors for tardive dyskinesia
Enthalten in PharmacoEconomics & outcomes news Bd. 794, 13.1.2018, Nr. 1, date:1.2018: 2
|
|
|
|
318 |
ICER posts two draft scoping documents for two reviews
Enthalten in PharmacoEconomics & outcomes news Bd. 793, 16.12.2017, Nr. 1, date:12.2017: 1
|
|
|
|
319 |
ICER publishes draft report on emicizumab for haemophilia A
Enthalten in PharmacoEconomics & outcomes news Bd. 796, 10.2.2018, Nr. 1, date:2.2018: 3
|
|
|
|
320 |
ICER recommends price drop for voretigene neparvovec
Enthalten in PharmacoEconomics & outcomes news Bd. 795, 27.1.2018, Nr. 1, date:1.2018: 2
|
|
Administration
